Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine
<p>Abstract</p> <p>Background</p> <p>Currently licensed human vaccines are subtype-specific and do not protect against pandemic H5N1 viruses. Previously, our group has reported on the construction of an influenza virus-like particle (VLP) as a new generation candidate v...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-10-01
|
| Series: | Virology Journal |
| Online Access: | http://www.virologyj.com/content/5/1/131 |